ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMBS Amarantus Bioscience Holdings Inc (CE)

0.0001
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes

Amarantus Bioscience (CE) Financial Summary

The current AMBS market cap is 6.83k. The company's latest EPS is USD -0.0698 and P/E is 0.00.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 020M75k095k
Operating Income -2.84M18.33M-627k-148k-268k
Net Income -10.38M18.38M-627k-10.2M-4.76M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 3.48M24.79M24.87M14.71M10.21M
Total Liabilities 31.22M33.74M34.36M34.63M34.87M
Total Equity -27.74M-8.96M-9.48M-19.93M-24.67M

Cash Flow

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -6.9M1.02M-83k-9.93M-4.5M
Investing 6.07M-2.03M-81k9.97M4.5M
Financing 781k1.01M163k-45k N/A
Market Cap 6.83k
Price to Earnings Ratio 0.00
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 68.27M
Average Volume (1 week) 451.87k
Average Volume (1 Month) 848.98k
52 Week Change -90.00%
52 Week High 0.0016
52 Week Low 0.0001
Spread (Intraday) 0 (0%)

Company Info

Company Name Amarantus Bioscience Holdings Inc (CE)
Address 701 s carson street
carson city, nevada 89701
Website https://www.amarantus.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock